Sirkku Peltonen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

Molecular genetics & genomic medicine

NPJ Parkinson's disease

American journal of medical genetics. Part A

European journal of human genetics : EJHG

Turku University Hospital

University of Turku (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Turku University Hospital Sep 01 2001

Finland

Specialist in Dermatology :: Department of Dermatology

Education History

University of Turku Aug 15 1983 - Dec 15 1991

Finland

PHD :: Faculty of Medicine

Publications

Niina Loponen, Heli Ylä-Outinen, Roope A Kallionpää, Mikko Valtanen, Kari Auranen, Hannu Järveläinen, Sirkku Peltonen, Juha Peltonen
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes. Molecular genetics & genomic medicine 12 (1) (2023)
Roope A Kallionpää, Edvard Johansson, Petri Böckerman, Juha Peltonen, Sirkku Peltonen
The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland. European journal of human genetics : EJHG (2023)
Niina Loponen, Heli Ylä-Outinen, Roope A Kallionpää, Mikko Valtanen, Kari Auranen, Hannu Järveläinen, Sirkku Peltonen, Juha Peltonen
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes. Molecular genetics & genomic medicine 12 (1) (2023)
Dani Flinkman, Ye Hong, Jelena Gnjatovic, Prasannakumar Deshpande, Zsuzsanna Ortutay, Sirkku Peltonen, Valtteri Kaasinen, Peter James, Eleanor Coffey
Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson's disease. NPJ Parkinson's disease 9 (1) (2023)
Niina Loponen, Heli Ylä-Outinen, Roope A Kallionpää, Mikko Valtanen, Kari Auranen, Hannu Järveläinen, Sirkku Peltonen, Juha Peltonen
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes. Molecular genetics & genomic medicine (2023)
Dani Flinkman, Ye Hong, Jelena Gnjatovic, Prasannakumar Deshpande, Zsuzsanna Ortutay, Sirkku Peltonen, Valtteri Kaasinen, Peter James, Eleanor Coffey
Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson's disease. NPJ Parkinson's disease 9 (1) (2023)
Niina Loponen, Heli Ylä-Outinen, Roope A Kallionpää, Mikko Valtanen, Kari Auranen, Hannu Järveläinen, Sirkku Peltonen, Juha Peltonen
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes. Molecular genetics & genomic medicine (2023)
Dani Flinkman, Ye Hong, Jelena Gnjatovic, Prasannakumar Deshpande, Zsuzsanna Ortutay, Sirkku Peltonen, Valtteri Kaasinen, Peter James, Eleanor Coffey
Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson's disease. NPJ Parkinson's disease 9 (1) (2023)
Niina Loponen, Heli Ylä-Outinen, Roope A Kallionpää, Mikko Valtanen, Kari Auranen, Hannu Järveläinen, Sirkku Peltonen, Juha Peltonen
Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes. Molecular genetics & genomic medicine (2023)
Rahime Inci, Theofanis Zagoras, Despoina Kantere, Peter Holmström, Martin Gillstedt, Sam Polesie, Sirkku Peltonen
Porokeratosis is one of the most common genodermatoses and is associated with an increased risk of keratinocyte cancer and melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Roope A Kallionpää, Kaisa Ahramo, Marianna Aaltonen, Paula Pennanen, Juha Peltonen, Sirkku Peltonen
Circulating free DNA in the plasma of individuals with neurofibromatosis type 1. American journal of medical genetics. Part A 185 (4) (2021)
Edvard Johansson, Roope A Kallionpää, Petri Böckerman, Juha Peltonen, Sirkku Peltonen
A rare disease and education: Neurofibromatosis type 1 decreases educational attainment. Clinical genetics 99 (4) (2021)
Sirkku Peltonen, Roope A Kallionpää, Matti Rantanen, Elina Uusitalo, Päivi M Lähteenmäki, Minna Pöyhönen, Janne Pitkäniemi, Juha Peltonen
Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study. International journal of cancer 145 (11) (2019)
D Gareth R Evans, Roope A Kallionpää, Maurizio Clementi, Eva Trevisson, Victor-Felix Mautner, Sacha J Howell, Lauren Lewis, Ouidad Zehou, Sirkku Peltonen, Antonella Brunello, Elaine F Harkness, Pierre Wolkenstein, Juha Peltonen
Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study. Genetics in medicine : official journal of the American College of Medical Genetics 22 (2) (2019)
Heli Ylä-Outinen, Niina Loponen, Roope A Kallionpää, Sirkku Peltonen, Juha Peltonen
Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST). Molecular genetics & genomic medicine 7 (9) (2019)

Sirkku Peltonen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sirkku Peltonen